Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: Mol Cancer Ther. 2009 Jul 28;8(8):2211–2220. doi: 10.1158/1535-7163.MCT-09-0327

Figure 2.

Figure 2

Bortezomib induces cellular STAT3 activity. UM-22B cells were stably transfected with pLucTKSIE, which contains two copies of the STAT3-responsive hSIE element upstream from a luciferase reporter gene. The UM-22B/pLucTKSIE cells were treated with bortezomib (20 nmol/L) for the indicated lengths of time, followed by luciferase assays. The data are plotted as fold induction of luciferase activity relative to untreated cells. Columns, mean of three independent experiments; bars, SE.